Showing results (131-140 of 251) with videos related to

Sort By:
Pageof 26
Plos One|October 25, 2007
Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trialsAnsar A Pathan, Clare R Sander, Helen A Fletcher, et al.
Plos One|November 27, 2013
A multi-antigenic adenoviral-vectored vaccine improves BCG-induced protection of goats against pulmonary tuberculosis infection and prevents disease progressionBernat Pérez de Val, Enric Vidal, Bernardo Villarreal-Ramos, et al.
Vaccine|August 7, 2008
Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1Helen A Fletcher, Ansar A Pathan, Tamara K Berthoud, et al.
Frontiers in Immunology|July 18, 2018
Elevated IgG Responses in Infants Are Associated With Reduced Prevalence of Mycobacterium tuberculosis InfectionErin Logan, Angelique Kany Kany Luabeya, Humphrey Mulenga, et al.
Plos One|November 12, 2015
Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine TrialErick Wekesa Bunyasi, Michele Tameris, Hennie Geldenhuys, et al.
Journal of the American Medical Informatics Association : JAMIA|August 10, 2004
Organization and representation of patient safety data: current status and issues around generalizability and scalabilityAziz A Boxwala, Meghan Dierks, Maura Keenan, et al.
The Journal of Infectious Diseases|March 17, 2018
Human Immunodeficiency Virus Infection Impairs Th1 and Th17 Mycobacterium tuberculosis-Specific T-Cell ResponsesLyle W Murray, Iman Satti, Jodi Meyerowitz, et al.
BMC Infectious Diseases|August 14, 2016
A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosisAndrea Zelmer, Rachel Tanner, Elena Stylianou, et al.
Plos One|January 12, 2018
Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M.tb infection modelRachel Harrington-Kandt, Elena Stylianou, Lucy A Eddowes, et al.
The Lancet. Infectious Diseases|August 25, 2014
Safety and immunogenicity of a candidate tuberculosis vaccine MVA85A delivered by aerosol in BCG-vaccinated healthy adults: a phase 1, double-blind, randomised controlled trialIman Satti, Joel Meyer, Stephanie A Harris, et al.
Pageof 26